Peter Würtz and Nikolaos Tertipis from Nightingale Health are visiting the Centre for Fertility and Health.
Peter Würtz will be talking about "NMR Metabolomics in large-scale cohorts: Molecular insights and translational outlook". The presentation will focus on scientific applications of the metabolomics platform to a wide range of chronic diseases, including the onset of diabetes and related complications, cardiovascular diseases, certain cancers as well as frailty and ageing. It will also touch upon combining metabolomics data and genetics to enhance drug development. As an example, it will then go on to elaborate on how the translation of such study results to individual patient use will be outlined in terms of enhanced disease prediction and health tracking, as already adopted by private healthcare in Scandinavia. To conclude, the presentation will demonstrate how the cost-effective measurement of numerous blood biomarkers in one go opens up a whole new spectrum of applications in large biobanks with rapid integration to preventive care.